Wang L, Wang S, Zhang X, Jia Z. Impact of regions with COVID-19 cases on COVID-zero regions by population mobility—worldwide, 2021. China CDC Wkly. 2022;4:79–82.
Article
PubMed
PubMed Central
Google Scholar
Sachs JD, Karim SSA, Aknin L, Allen J, Brosbøl K, Colombo F, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. 2022;400:1224–80.
Article
PubMed
PubMed Central
Google Scholar
Wang X, Cai Y, Zhang B, Zhang X, Wang L, Yan X, et al. Cost-effectiveness analysis on COVID-19 surveillance strategy of large-scale sports competition. Infect Dis Poverty. 2022;11:32.
Article
PubMed
PubMed Central
Google Scholar
Larkin HD. Global COVID-19 death toll may be triple the reported deaths. JAMA. 2022;327:1438.
PubMed
Google Scholar
Guan D, Wang D, Hallegatte S, Davis SJ, Huo J, Li S, et al. Global supply-chain effects of COVID-19 control measures. Nat Hum Behav. 2020;4:577–87.
Article
PubMed
Google Scholar
Polonsky JA, Bhatia S, Fraser K, Hamlet A, Skarp J, Stopard IJ, et al. Feasibility, acceptability, and effectiveness of non-pharmaceutical interventions against infectious diseases among crisis-affected populations: a scoping review. Infect Dis Poverty. 2022;11:14.
Article
PubMed
PubMed Central
Google Scholar
Barouch DH. Covid-19 vaccines—immunity, variants, boosters. N Engl J Med. 2022;387:1011–20.
Article
CAS
PubMed
Google Scholar
Guo Q, Ruhan A, Liang L, Zhao X, Deng A, Hu Y, et al. An imported case of BA.2 lineage of Omicron variant COVID-19—Guangdong Province, China, December 28, 2021. China CDC Wkly. 2022;4:98–9.
Article
PubMed
PubMed Central
Google Scholar
Hu T, Zhang M, Deng A, Zhang Y, Li B, Li Y, et al. Comparison of Omicron and Delta variant infection COVID-19 cases—Guangdong Province, China, 2022. China CDC Wkly. 2022;4:385–8.
PubMed
PubMed Central
Google Scholar
Young M, Crook H, Scott J, Edison P. Covid-19: virology, variants, and vaccines. BMJ Med. 2022;1: e000040.
Article
Google Scholar
Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602:671–5.
Article
CAS
PubMed
Google Scholar
Bilinski A, Emanuel EJ. COVID-19 and excess all-cause mortality in the US and 18 comparison countries. JAMA. 2020;324:2100–2.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jørgensen SB, Nygård K, Kacelnik O, Telle K. Secondary attack rates for Omicron and Delta variants of SARS-CoV-2 in Norwegian households. JAMA. 2022;327:1610–1.
Article
PubMed
PubMed Central
Google Scholar
Zheng B, Zhu W, Pan J, Wang W. Patterns of human social contact and mask wearing in high-risk groups in China. Infect Dis Poverty. 2022;11:69.
Article
PubMed
PubMed Central
Google Scholar
Pan J, Zhu W, Tian J, Liu Z, Xu A, Yao Y, et al. Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19. Infect Dis Poverty. 2022;11:36.
Article
PubMed
PubMed Central
Google Scholar
Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A, et al. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat Med. 2022;28:1491–500.
Article
CAS
PubMed
Google Scholar
Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Amir O, Freedman L, et al. Protection by a fourth dose of BNT162b2 against Omicron in Israel. N Engl J Med. 2022;386:1712–20.
Article
CAS
PubMed
Google Scholar
Arbel R, Wolff Sagy Y, Hoshen M, Battat E, Lavie G, Sergienko R, et al. Nirmatrelvir use and severe Covid-19 outcomes during the Omicron surge. N Engl J Med. 2022;387:790–8.
Article
CAS
PubMed
Google Scholar
Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ, Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study. Lancet Public Health. 2020;5:e375-85.
Article
PubMed
PubMed Central
Google Scholar
Huang Z, Xu S, Liu J, Wu L, Qiu J, Wang N, et al. Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 variant infection, severe illness, and death. BMC Med. 2022;20:400.
Article
CAS
PubMed
PubMed Central
Google Scholar
He G, Zeng F, Xiao J, Zhao J, Liu T, Hu J, et al. When and how to adjust non-pharmacological interventions concurrent with booster vaccinations against COVID-19—Guangdong, China, 2022. China CDC Wkly. 2022;4:199–206.
Article
PubMed
PubMed Central
Google Scholar
Zhou F, Hu TJ, Zhang XY, Lai K, Chen JH, Zhou XH. The association of intensity and duration of non-pharmacological interventions and implementation of vaccination with COVID-19 infection, death, and excess mortality: natural experiment in 22 European countries. J Infect Public Health. 2022;15:499–507.
Article
PubMed
PubMed Central
Google Scholar
Zu J, Li ML, Li ZF, Shen MW, Xiao YN, Ji FP. Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data- and model-driven study. Infect Dis Poverty. 2020;9:83.
Article
PubMed
PubMed Central
Google Scholar
Chen M, Ai L, Huang D, Chen J, Feng T, Mei S, et al. Soaring asymptomatic infected individuals bring about barriers and difficulties for interruption of COVID-19 prevalence in China. Vector Borne Zoonotic Dis. 2021;21:777–84.
Article
CAS
PubMed
Google Scholar
Zhang SX, Yang M, Zheng JX, Zhang BQ, Pan CH, Tian LG. Comprehensive strategies and measures to control COVID-19. Infect Dis Poverty. 2022;11:67.
Article
PubMed
PubMed Central
Google Scholar
Chen Z, Deng X, Fang L, Sun K, Wu Y, Che T, et al. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study. Lancet Reg Health West Pac. 2022;29: 100592.
Article
PubMed
PubMed Central
Google Scholar
Ye L, Li WF, Shao J, Xu Z, Ju J, Xu H. Fighting Omicron epidemic in China: real-world big data from Fangcang shelter hospital during the outbreak in Shanghai 2022. J Infect. 2022;85:436–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7:141.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sherratt K, Abbott S, Meakin SR, Hellewell J, Munday JD, Bosse N, et al. Exploring surveillance data biases when estimating the reproduction number: with insights into subpopulation transmission of COVID-19 in England. Philos Trans R Soc Lond B Biol Sci. 2021;376:20200283.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jin S, Dickens BL, Lim JT, Cook AR. EpiRegress: a method to estimate and predict the time-varying effective reproduction number. Viruses. 2022;14:1576.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ganyani T, Kremer C, Chen D, Torneri A, Faes C, Wallinga J, et al. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro Surveill. 2020;25:2000257.
Article
PubMed
PubMed Central
Google Scholar
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172:577–82.
Article
PubMed
Google Scholar
Mefsin YM, Chen D, Bond HS, Lin Y, Cheung JK, Wong JY, et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant, Hong Kong, January–March 2022. Emerg Infect Dis. 2022;28:1856–8.
Article
PubMed
PubMed Central
Google Scholar
Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis. JAMA Netw Open. 2022;5: e2228008.
Article
PubMed
PubMed Central
Google Scholar
Yuan P, Tan Y, Yang L, Aruffo E, Ogden NH, Yang G, et al. Assessing the mechanism of citywide test-trace-isolate Zero-COVID policy and exit strategy of COVID-19 pandemic. Infect Dis Poverty. 2022;11:104.
Article
PubMed
PubMed Central
Google Scholar
Li X, Zhang Z, Lyu K, Xu D. Strengthening community defenses to prevent and control the spread of COVID-19 in China. China CDC Wkly. 2022;4:191–4.
Article
PubMed
PubMed Central
Google Scholar
Erikstrup C, Laksafoss AD, Gladov J, Kaspersen KA, Mikkelsen S, Hindhede L, et al. Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: a nationwide serosurveillance study. Lancet Reg Health Eur. 2022;21: 100479.
Article
PubMed
PubMed Central
Google Scholar
Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. Lancet. 2022;399:1513–36.
Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400:452–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jain R, Dupas P. The effects of India’s COVID-19 lockdown on critical non-COVID health care and outcomes: evidence from dialysis patients. Soc Sci Med. 2022;296: 114762.
Article
PubMed
PubMed Central
Google Scholar
Zou H, Shu Y, Feng T. How Shenzhen, China avoided widespread community transmission: a potential model for successful prevention and control of COVID-19. Infect Dis Poverty. 2020;9:89.
Article
PubMed
PubMed Central
Google Scholar
Kong L, Duan M, Shi J, Hong J, Zhou X, Yang X, et al. Optimization of COVID-19 prevention and control measures during the Beijing 2022 Winter Olympics: a model-based study. Infect Dis Poverty. 2022;11:95.
Article
PubMed
PubMed Central
Google Scholar
Kucharski AJ, Klepac P, Conlan AJK, Kissler SM, Tang ML, Fry H, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis. 2020;20:1151–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lefrançois T, Malvy D, Atlani-Duault L, Benamouzig D, Druais PL, Yazdanpanah Y, et al. After 2 years of the COVID-19 pandemic, translating One Health into action is urgent. Lancet. 2022. https://doi.org/10.1016/S0140-6736(22)01840-2.
Article
PubMed
PubMed Central
Google Scholar
Han E, Tan MMJ, Turk E, Sridhar D, Leung GM, Shibuya K, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396:1525–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gandjour A. Cost-effectiveness of future lockdown policies against the COVID-19 pandemic. Health Serv Manage Res. 2022. https://doi.org/10.1177/09514848221080687.
Article
PubMed
PubMed Central
Google Scholar
Reddy KP, Shebl FM, Foote JHA, Harling G, Scott JA, Panella C, Fitzmaurice KP, et al. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet Glob Health. 2021;9:e120–29.
Nuñez MA, Pauchard A, Ricciardi A. Invasion science and the global spread of SARS-CoV-2. Trends Ecol Evol. 2020;35:642–5.
Article
PubMed
PubMed Central
Google Scholar
Fei SW, Gu SY, Chen FM, Zhou N, Cheng ZL, Xie Y, et al. Towards a global One Health index: a potential assessment tool for One Health performance. Infect Dis Poverty. 2022;11:57.
Article
PubMed
PubMed Central
Google Scholar
Li Q, Bergquist R, Grant L, Song JX, Feng XY, Zhou XN. Consideration of COVID-19 beyond the human-centred approach of prevention and control: the ONE-HEALTH perspective. Emerg Microb Infect. 2022;11:2520–8.
Article
Google Scholar
Zhang XX, Liu JS, Han LF, Simm G, Guo XK, Zhou XN. One Health: new evaluation framework launched. Nature. 2022;604(7907):625.
Article
CAS
PubMed
Google Scholar